393 related articles for article (PubMed ID: 35636015)
1. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of autophagy induced by activation of the AMPK/ERK/mTOR signaling pathway after TRIM22-mediated DENV-2 infection of HUVECs.
Wu N; Gou X; Hu P; Chen Y; Ji J; Wang Y; Zuo L
Virol J; 2022 Dec; 19(1):228. PubMed ID: 36587218
[TBL] [Abstract][Full Text] [Related]
3. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
4. TRIM22 facilitates autophagosome-lysosome fusion by mediating the association of GABARAPs and PLEKHM1.
Heo H; Park H; Lee MS; Kim J; Kim J; Jung SY; Kim SK; Lee S; Chang J
Autophagy; 2024 May; 20(5):1098-1113. PubMed ID: 38009729
[TBL] [Abstract][Full Text] [Related]
5. Targeting autophagy to modulate hepatic ischemia/reperfusion injury: A comparative study between octreotide and melatonin as autophagy modulators through AMPK/PI3K/AKT/mTOR/ULK1 and Keap1/Nrf2 signaling pathways in rats.
Mohamed DZ; El-Sisi AEE; Sokar SS; Shebl AM; Abu-Risha SE
Eur J Pharmacol; 2021 Apr; 897():173920. PubMed ID: 33571535
[TBL] [Abstract][Full Text] [Related]
6. Functional Teas from Penthorum chinense Pursh Alleviates Ethanol-Induced Hepatic Oxidative Stress and Autophagy Impairment in Zebrafish via Modulating the AMPK/p62/Nrf2/mTOR Signaling Axis.
Zhao X; Zhou M; Deng Y; Guo C; Liao L; He L; Peng C; Li Y
Plant Foods Hum Nutr; 2022 Dec; 77(4):514-520. PubMed ID: 36103040
[TBL] [Abstract][Full Text] [Related]
7. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation.
Li S; Li J; Shen C; Zhang X; Sun S; Cho M; Sun C; Song Z
Biochim Biophys Acta; 2014 Jan; 1841(1):22-33. PubMed ID: 24055888
[TBL] [Abstract][Full Text] [Related]
8. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway.
Li L; Qi Y; Ma X; Xiong G; Wang L; Bao C
Cell Biol Int; 2018 Sep; 42(9):1192-1199. PubMed ID: 29762880
[TBL] [Abstract][Full Text] [Related]
9. TRIM22 actives PI3K/Akt/mTOR pathway to promote psoriasis through enhancing cell proliferation and inflammation and inhibiting autophagy.
Ren Y; Dong H; Jin R; Jiang J; Zhang X
Cutan Ocul Toxicol; 2022 Dec; 41(4):304-309. PubMed ID: 36170453
[TBL] [Abstract][Full Text] [Related]
10. DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1-Mediated NRF2 Ubiquitination.
Wang X; Zhou T; Yang X; Cao X; Jin G; Zhang P; Guo J; Rong K; Li B; Hu Y; Liu K; Ma P; Qin A; Zhao J
Adv Sci (Weinh); 2023 May; 10(14):e2204438. PubMed ID: 36965071
[TBL] [Abstract][Full Text] [Related]
11. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
12. TRIM22 regulates macrophage autophagy and enhances Mycobacterium tuberculosis clearance by targeting the nuclear factor-multiplicity κB/beclin 1 pathway.
Lou J; Wang Y; Zheng X; Qiu W
J Cell Biochem; 2018 Nov; 119(11):8971-8980. PubMed ID: 30011088
[TBL] [Abstract][Full Text] [Related]
13. Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity.
Park JS; Lee DH; Lee YS; Oh E; Bae KH; Oh KJ; Kim H; Bae SH
Autophagy; 2020 Jan; 16(1):86-105. PubMed ID: 30907226
[TBL] [Abstract][Full Text] [Related]
14. TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway.
Yu B; Zhou Y; He J
Cell Cycle; 2023 Jun; 22(12):1496-1513. PubMed ID: 37245083
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 activates Nrf2 via autophagic degradation of Keap1 and activation of AMPK in human cancer cells.
Jang DE; Song J; Park JW; Yoon SH; Bae YS
BMB Rep; 2020 May; 53(5):272-277. PubMed ID: 32317087
[TBL] [Abstract][Full Text] [Related]
16. E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway.
Liang M; Wang L; Sun Z; Chen X; Wang H; Qin L; Zhao W; Geng B
Cell Commun Signal; 2022 May; 20(1):62. PubMed ID: 35534896
[TBL] [Abstract][Full Text] [Related]
17. HCV-induced oxidative stress by inhibition of Nrf2 triggers autophagy and favors release of viral particles.
Medvedev R; Ploen D; Spengler C; Elgner F; Ren H; Bunten S; Hildt E
Free Radic Biol Med; 2017 Sep; 110():300-315. PubMed ID: 28673615
[TBL] [Abstract][Full Text] [Related]
18. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
19. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1.
Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z
Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577
[TBL] [Abstract][Full Text] [Related]
20. EGCG-induced selective death of cancer cells through autophagy-dependent regulation of the p62-mediated antioxidant survival pathway.
Lee HW; Choi JH; Seo D; Gavaachimed L; Choi J; Park S; Min NY; Lee DH; Bang HW; Ham SW; Kim JW; Lee SC; Rhee S; Seo SB; Lee KH
Biochim Biophys Acta Mol Cell Res; 2024 Mar; 1871(3):119659. PubMed ID: 38216089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
